Archives

The Bank of Nova Scotia has filed a preliminary pricing supplement for a new structured debt offering consisting of autocallable contingent buffered return notes due August 5, 2031. The notes, which are expected to price on July 31, 2026, are linked to the performance of three reference assets: the State Street SPDR S&P Regional Banking ETF, the S&P 500 Index, and the State Street Energy Select Sector SPDR ETF. The offering represents an alternative investment vehicle for investors seeking exposure to sector-specific performance with embedded call and downside buffer features.

• July 23, 2026 08:13 AM PDT
• Anjali Anand

Improving demand, stronger quarterly execution, embedded computing exposure, and supportive analyst sentiment are strengthening the company’s recovery narrative as semiconductor conditions gradually become healthier across key end markets.

• July 23, 2026 08:13 AM PDT
• Anmol Khazanchi

loanDepot’s upcoming results may reveal how mortgage demand, digital lending, expense management, and housing affordability are influencing its operating performance and strategic direction across the United States.

• July 23, 2026 08:08 AM PDT
• Anmol Khazanchi

Navient faces cautious sentiment as earnings resilience competes with negative margins, heavy leverage, and dividend concerns, leaving future confidence dependent on stronger profitability and disciplined financial execution.

• July 23, 2026 08:04 AM PDT
• Anmol Khazanchi

Galectin Therapeutics has crossed a major technical trend line, but lasting momentum depends on clinical execution, funding strength, regulatory progress, and evidence supporting its experimental liver disease therapy.

• July 23, 2026 08:00 AM PDT
• Anmol Khazanchi

Improved guidance, recurring revenue, diversified technology businesses, disciplined acquisitions, and continued operational execution reinforce confidence in the company's long-term business direction despite evolving market conditions.

• July 23, 2026 07:56 AM PDT
• Anmol Khazanchi

Molina Healthcare, Inc. disclosed its second quarter 2026 financial results and portfolio activity in a quarterly update filed on July 23, 2026. The filing provides consolidated financial statements and detailed disclosures covering the six-month period ended June 30, 2026, alongside comparative periods from 2025. The company's announcement includes information on its health plan operations, investment portfolio composition, and fair value measurements across multiple asset classes.

• July 23, 2026 07:51 AM PDT
• Anjali Anand

Strong earnings, connected-device demand, cloud services, and industrial automation support momentum, while elevated valuation, competition, cybersecurity exposure, and execution requirements remain central to the future outlook.

• July 23, 2026 07:51 AM PDT
• Anmol Khazanchi

A major technical breakout and improving quarterly results have strengthened market attention, while profitability pressure, debt exposure, and uncertain consumer demand continue testing the durability of the broader recovery.

• July 23, 2026 07:48 AM PDT
• Anmol Khazanchi

Eli Lilly combines powerful earnings momentum, strong profitability, financial stability, and an organized chart base, creating a closely watched setup as the company approaches its next technical market test.

• July 23, 2026 07:43 AM PDT
• Anmol Khazanchi